New episode of our video podcast, Speaking of Litigation: When it comes to dietary supplement class actions, there’s a little less class and a lot more action.
In this episode of Speaking of Litigation, Epstein Becker Green litigators Teddy McCormick, Jack Wenik, and Robert Lufrano explore the litigious minefield of class action battles, particularly focusing on the challenges faced by companies amid the proliferation of legal opportunists and lawsuits based on U.S. Food and Drug Administration (FDA) warning letters.
From navigating consumer protection statutes to deciphering FDA actions, our panelists discuss the legal intricacies shaping the dietary supplement industry's future. Tune in for an engaging conversation that unpacks the intersection of law, regulation, and commerce in the realm of dietary supplements.
Blog Editors
Recent Updates
- The Department of Justice’s COVID-19 Enforcement Task Force 2024 Report: A Continued Commitment to Combatting COVID-19-Related Fraud
- Dissecting the New FTC Final Rule That Regulates “Fake Reviews” and More
- DOJ Launches the Corporate Whistleblower Awards Pilot Program
- Making the Lawyer-Client Relationship Work in Challenging Litigation – Speaking of Litigation Video Podcast
- Authors Predict an Increase in the Use of State Court Receivership Proceedings